Back to libraryMetabolic

Pancragen

Research profile · How we handle evidence

Khavinson bioregulator peptide researched for pancreatic function and metabolic support.

Evidence Score

43/100

Preclinical signal

Category

Metabolic

Therapeutic area

Standard Dose

5-10mg

Daily

Half-life

~8 hr

Plasma elimination

Route

SC

Subcutaneous

Safety Tier

3

Limited data

Overview

Pancragen is a Khavinson bioregulator peptide researched for pancreatic tissue support. It’s usually framed as organ-level support rather than a quick glucose-lowering tool. If you use it in a routine, the expectation is more about gradual, supportive changes that you can track with routine metabolic markers.

Mechanism of Action

Pancragen is a Khavinson bioregulator peptide researched for pancreatic tissue support. It’s usually framed as organ-level support rather than a quick glucose-lowering tool. If you use it in a routine, the expectation is more about gradual, supportive changes that you can track with routine metabolic markers.

MetabolicWellness

pH & Mixing

4.2

Peptides reconstituted at very different pH levels can destabilize when combined in the same syringe, which lowers how much of the peptide your body actually absorbs. If you're unsure whether two peptides are close enough in pH, reconstitute and inject them separately.

A dedicated compatibility check between two specific peptides is coming to the Compare tool. This section covers this peptide's pH only.

Benefits

  • Pancreatic support
  • Blood sugar regulation
  • Insulin sensitivity
  • Metabolic health

Side Effects

  • Generally well-tolerated

Contraindications

No entries listed.

Structure & Sequence

Verified structure

Pancragen

Illustration uses the catalog amino acid sequence because no exact external registry match was confirmed.

Sequence-backed
C26H36N6O9576.25 Da4 residues
Amino Acid Sequence
Lys-Glu-Asp-Trp (KEDW)
Molecular Weight
576.25 Da
Chemical Formula
C26H36N6O9
CAS Number
N/A
Reconstituted pH
4.2

Stack & Route Context

Stacks with

  • Metformin
  • Berberine

Administration

Subcutaneous

Research Status

Research peptide for metabolic health

Approval Status

Preclinical

Sports Legal

Permitted

References

  1. 1

    Impacts of pancragen on the differentiation of pancreatic cells during their aging

    2013

    View source
  2. 2

    Pancragen — research peptide product profile

    View source
  3. 3

    Pancragen bioregulator product page (research information)

    View source

This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.

Research-driven insights.Evidence-based decisions.